Diabetes, Vol 43, Issue 4 564-571, Copyright © 1994 by American Diabetes Association

ARTICLES

Time courses of changes in hepatic and skeletal muscle insulin action and GLUT4 protein in skeletal muscle after STZ injection

JH Youn, JK Kim and TA Buchanan
Department of Physiology and Biophysics, University of Southern California School of Medicine, Los Angeles 90033.

To determine the relative time courses of changes in peripheral and hepatic insulin action and skeletal muscle GLUT4 protein levels after a streptozotocin (STZ) injection in rats, we performed hyperinsulinemic (14-18 nM), euglycemic (7.5 mM) clamps in control (n = 8) and diabetic rats at 1 (n = 7), 3 (n = 8), 7 (n = 8), and 14 (n = 6) days after intraperitoneal STZ (65 mg/kg). Basal plasma glucose concentrations increased from 8.1 +/- 0.2 mM in control rats to 23.5 +/- 1.2 mM 1 day after STZ (P < 0.01) and remained constant thereafter. Basal plasma insulin levels were approximately 35% of control levels in all STZ groups (P < 0.01). Insulin-stimulated whole-body glucose uptake decreased significantly as early as one day after STZ injection (P < 0.01), resulting predominantly from a decrease in whole-body glycolysis. Insulin action to suppress hepatic glucose output was normal on day 1 after STZ but impaired markedly on day 3 and thereafter (P < 0.01). Insulin-stimulated glucose uptake in individual skeletal muscles was not altered until day 7 after STZ, and the magnitudes of decreases in skeletal muscle insulin action on days 7 and 14 were not fully accounted for by the decreases in GLUT4 protein level measured from the same muscles. Our data indicate that there is a temporal hierarchy in the development of insulin resistance in STZ-induced diabetes.(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				Y.-R. Cho, H.-J. Kim, S.-Y. Park, H. J. Ko, E.-G. Hong, T. Higashimori, Z. Zhang, D. Y. Jung, M. S. Ola, K. F. LaNoue, et al. Hyperglycemia, maturity-onset obesity, and insulin resistance in NONcNZO10/LtJ males, a new mouse model of type 2 diabetes Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E327 - E336. [Abstract] [Full Text] [PDF]

				S. P. R. Rao, R. Wassell, M. A. Shaw, and K. Sharma Profiling of human mesangial cell subproteomes reveals a role for calmodulin in glucose uptake Am J Physiol Renal Physiol, April 1, 2007; 292(4): F1182 - F1189. [Abstract] [Full Text] [PDF]

				M. M. Haluzik, Z. Lacinova, M. Dolinkova, D. Haluzikova, D. Housa, A. Horinek, Z. Vernerova, T. Kumstyrova, and M. Haluzik Improvement of Insulin Sensitivity after Peroxisome Proliferator-Activated Receptor-{alpha} Agonist Treatment Is Accompanied by Paradoxical Increase of Circulating Resistin Levels Endocrinology, September 1, 2006; 147(9): 4517 - 4524. [Abstract] [Full Text] [PDF]

				Y. I. Kim, F. N. Lee, W. S. Choi, S. Lee, and J. H. Youn Insulin Regulation of Skeletal Muscle PDK4 mRNA Expression Is Impaired in Acute Insulin-Resistant States. Diabetes, August 1, 2006; 55(8): 2311 - 2317. [Abstract] [Full Text] [PDF]

				B. Qin, M. Nagasaki, M. Ren, G. Bajotto, Y. Oshida, and Y. Sato Gosha-jinki-gan (a Herbal Complex) Corrects Abnormal Insulin Signaling Evid. Based Complement. Altern. Med., December 1, 2004; 1(3): 269 - 276. [Abstract] [Full Text] [PDF]

				M. Chen, M. Haluzik, N. J. Wolf, J. Lorenzo, K. R. Dietz, M. L. Reitman, and L. S. Weinstein Increased Insulin Sensitivity in Paternal Gnas Knockout Mice Is Associated with Increased Lipid Clearance Endocrinology, September 1, 2004; 145(9): 4094 - 4102. [Abstract] [Full Text] [PDF]

				C. Broca, V. Breil, C. Cruciani-Guglielmacci, M. Manteghetti, C. Rouault, M. Derouet, S. Rizkalla, B. Pau, P. Petit, G. Ribes, et al. Insulinotropic agent ID-1101 (4-hydroxyisoleucine) activates insulin signaling in rat Am J Physiol Endocrinol Metab, September 1, 2004; 287(3): E463 - E471. [Abstract] [Full Text] [PDF]

				M. Haluzik, C. Colombo, O. Gavrilova, S. Chua, N. Wolf, M. Chen, B. Stannard, K. R. Dietz, D. Le Roith, and M. L. Reitman Genetic Background (C57BL/6J Versus FVB/N) Strongly Influences the Severity of Diabetes and Insulin Resistance in ob/ob Mice Endocrinology, July 1, 2004; 145(7): 3258 - 3264. [Abstract] [Full Text] [PDF]

				M. Haluzik, O. Gavrilova, and D. LeRoith Peroxisome Proliferator-Activated Receptor-{alpha} Deficiency Does Not Alter Insulin Sensitivity in Mice Maintained on Regular or High-Fat Diet: Hyperinsulinemic-Euglycemic Clamp Studies Endocrinology, April 1, 2004; 145(4): 1662 - 1667. [Abstract] [Full Text] [PDF]

				E. H. Koh, M.-S. Kim, J.-Y. Park, H. S. Kim, J.-Y. Youn, H.-S. Park, J. H. Youn, and K.-U. Lee Peroxisome Proliferator-Activated Receptor (PPAR)-{alpha} Activation Prevents Diabetes in OLETF Rats: Comparison With PPAR-{gamma} Activation Diabetes, September 1, 2003; 52(9): 2331 - 2337. [Abstract] [Full Text] [PDF]

				C.-H. Wang, N. Leung, N. Lapointe, L. Szeto, K. D. Uffelman, A. Giacca, J. L. Rouleau, and G. F. Lewis Vasopeptidase Inhibitor Omapatrilat Induces Profound Insulin Sensitization and Increases Myocardial Glucose Uptake in Zucker Fatty Rats: Studies Comparing a Vasopeptidase Inhibitor, Angiotensin-Converting Enzyme Inhibitor, and Angiotensin II Type I Receptor Blocker Circulation, April 15, 2003; 107(14): 1923 - 1929. [Abstract] [Full Text] [PDF]

				T. Yamashita, A. Hashiramoto, M. Haluzik, H. Mizukami, S. Beck, A. Norton, M. Kono, S. Tsuji, J. L. Daniotti, N. Werth, et al. Enhanced insulin sensitivity in mice lacking ganglioside GM3 PNAS, March 18, 2003; 100(6): 3445 - 3449. [Abstract] [Full Text] [PDF]

				C. Colombo, M. Haluzik, J. J. Cutson, K. R. Dietz, B. Marcus-Samuels, C. Vinson, O. Gavrilova, and M. L. Reitman Opposite Effects of Background Genotype on Muscle and Liver Insulin Sensitivity of Lipoatrophic Mice. ROLE OF TRIGLYCERIDE CLEARANCE J. Biol. Chem., January 31, 2003; 278(6): 3992 - 3999. [Abstract] [Full Text] [PDF]

				M. Haluzik, K. R. Dietz, J. K. Kim, B. Marcus-Samuels, G. I. Shulman, O. Gavrilova, and M. L. Reitman Adrenalectomy Improves Diabetes in A-ZIP/F-1 Lipoatrophic Mice by Increasing Both Liver and Muscle Insulin Sensitivity Diabetes, July 1, 2002; 51(7): 2113 - 2118. [Abstract] [Full Text] [PDF]

				C. S. Choi, C. B. Thompson, P. K. K. Leong, A. A. McDonough, and J. H. Youn Short-term K+ deprivation provokes insulin resistance of cellular K+ uptake revealed with the K+ clamp Am J Physiol Renal Physiol, January 1, 2001; 280(1): F95 - F102. [Abstract] [Full Text] [PDF]

				J. K. Kim, O. Gavrilova, Y. Chen, M. L. Reitman, and G. I. Shulman Mechanism of Insulin Resistance in A-ZIP/F-1 Fatless Mice J. Biol. Chem., March 17, 2000; 275(12): 8456 - 8460. [Abstract] [Full Text] [PDF]

				J. K. Wi, J. K. Kim, and J. H. Youn Reduced glucose clearance as the major determinant of postabsorptive hyperglycemia in diabetic rats Am J Physiol Endocrinol Metab, February 1, 1998; 274(2): E257 - E264. [Abstract] [Full Text] [PDF]

				E. Tozzo, L. Gnudi, and B. B. Kahn Amelioration of Insulin Resistance in Streptozotocin Diabetic Mice by Transgenic Overexpression of GLUT4 Driven by an Adipose-Specific Promoter Endocrinology, April 1, 1997; 138(4): 1604 - 1611. [Abstract] [Full Text] [PDF]